Advances in the treatment of Crohn's disease and ulcerative

When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), reducing the need for steroids and risk of hospitalization.

Dr. Edward V. Loftus, MD, Rochester, MN, Gastroenterologist

Satellite Symposia - DDW

specialized ibd, SAVE 16%

Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

specialized ibd, SAVE 16%

NEPC20 AGENDA – Connecticut Pharmacists Association

NEPC20 AGENDA – Connecticut Pharmacists Association

NEPC20 AGENDA – Connecticut Pharmacists Association

Dr. Edward V. Loftus, MD, Rochester, MN, Gastroenterologist

Digestive Diseases News - Medical Professionals - Mayo Clinic

Are Biologics Right for You?